These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6251784)

  • 1. Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.
    Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
    Arch Virol; 1980; 65(3-4):237-46. PubMed ID: 6251784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants.
    Klein RJ; Friedman-Kien AE; DeStefano E
    Infect Immun; 1981 Dec; 34(3):693-701. PubMed ID: 6277789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
    Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
    Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
    Svennerholm B; Vahlne A; Lycke E
    Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
    Klein RJ
    Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
    Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
    Liu WG; Chen ZJ; Song JZ; Ma ZX
    Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and L-lysine on latent ganglionic herpes simplex virus in vitro.
    Park NH; Pavan-Langston D; Declercq E
    Am J Med; 1982 Jul; 73(1A):151-4. PubMed ID: 6285706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against establishment of latent infections in mice immunized with a non-pathogenic herpes simplex virus mutant and reinfected with the pathogenic parental strain.
    Klein RJ; Kaley LA; Friedman-Kien AE
    Vaccine; 1984 Sep; 2(3):219-23. PubMed ID: 6099650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection.
    Spivack JG; Fraser NW
    J Virol; 1988 May; 62(5):1479-85. PubMed ID: 2833602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
    Sibrack CD; McLaren C; Barry DW
    Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site.
    Klein RJ; Friedman-Kien AE; Brady E
    Arch Virol; 1978; 57(2):161-6. PubMed ID: 208489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice.
    Kastrukoff LF; Lau AS; Puterman ML
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():613-21. PubMed ID: 3007658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice.
    Gordon Y; Gilden DH; Shtram Y; Asher Y; Tabor E; Wellish M; Devlin M; Snipper D; Hadar J; Becker Y
    Arch Virol; 1983; 76(1):39-49. PubMed ID: 6305312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.
    Klein RJ; Friedman-Kien AE; Yellin PB
    Infect Immun; 1978 Apr; 20(1):130-5. PubMed ID: 208970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice.
    Klein RJ
    J Gen Virol; 1980 Aug; 49(2):401-5. PubMed ID: 6255074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prolonged cultivation in the presence of acyclovir on recovery of latent herpes simplex virus from human trigeminal ganglia.
    Lewis ME; Warren KG; Jeffrey VM; Tyrrell DL
    Antimicrob Agents Chemother; 1983 Mar; 23(3):487-9. PubMed ID: 6303216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus latency in the rabbit trigeminal ganglia: ganglionic superinfection.
    Centifanto-Fitzgerald YM; Rayfield M; Tian PY; Kaufman HE
    Proc Soc Exp Biol Med; 1985 May; 179(1):55-67. PubMed ID: 2986150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.
    Field HJ; Darby G
    Antimicrob Agents Chemother; 1980 Feb; 17(2):209-16. PubMed ID: 6247969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.